Hengfen Dai

6PUBLICATIONS
18CO-AUTHORS
Gene and molecular therapyMolecular targetsTissue engineeringNanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 18, 2023
Development and Validation of a Clinical Risk Score to Predict Immune-mediated Liver Injury Caused by Sintilimab: Assessed for Causality Using Updated RUCAM.

Caiyun Zheng, Shunmin Huang, Meimei Lin

|Feb 21, 2023
Hepatotoxicity of immune checkpoint inhibitors: What is Currently Known.

Caiyun Zheng, Shunmin Huang, Meimei Lin

|Apr 23, 2021
Effects of sodium-glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta-analysis of randomized controlled trials.

Caiyun Zheng, Meimei Lin, Yan Chen

|Mar 08, 2021
hsa-miR-4443 inhibits myocardial fibroblast proliferation by targeting THBS1 to regulate TGF-β1/α-SMA/collagen signaling in atrial fibrillation.

Jingwen Xiao, Yan Zhang, Yuan Tang

|Aug 05, 2020
Correction: Technology-Based Interventions in Oral Anticoagulation Management: Meta-Analysis of Randomized Controlled Trials.

Hengfen Dai, Caiyun Zheng, Chun Lin

|Jul 17, 2020
Technology-Based Interventions in Oral Anticoagulation Management: Meta-Analysis of Randomized Controlled Trials.

Hengfen Dai, Caiyun Zheng, Chun Lin

Pageof 1

Frequent Collaborators

4 joint publications

Caiyun Zheng

3 joint publications

Yan Zhang

3 joint publications

Jingwen Xiao

2 joint publications

Chun Lin